Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neonatal portal vein thrombosis: risk factors, diagnosis, treatment recommendations and review of the literature. | Thromb J | 2023 | 37271816 | PubTator, text mining | PubMed |
| Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad? | Endocr Rev | 2023 | 37253115 | PubTator, text mining | PubMed |
| A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patients. | Haemophilia | 2023 | 37252892 | PubTator, text mining | PubMed |
| New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond. | Expert Opin Pharmacother | 2023 | 37243619 | PubTator, text mining | PubMed |
| Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. | Int J Mol Sci | 2023 | 37240292 | PubTator, text mining | PubMed |
| Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia. | Biomedicines | 2023 | 37238908 | PubTator, text mining | PubMed |
| Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. | Thromb Haemost | 2023 | 37236229 | PubTator, text mining | PubMed |
| Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. | Obes Facts | 2023 | 37231905 | PubTator, text mining | PubMed |
| The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study. | BMC Med | 2023 | 37226166 | PubTator, text mining | PubMed |
| Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation. | Mol Genet Metab | 2023 | 37224763 | PubTator, text mining | PubMed |
| Harnessing Shannon entropy-based descriptors in machine learning models to enhance the prediction accuracy of molecular properties. | J Cheminform | 2023 | 37211605 | PubTator, text mining | PubMed |
| VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort. | EJHaem | 2023 | 37206292 | PubTator, text mining | PubMed |
| KMO in the promotion of tumor development and progression in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37201083 | PubTator, text mining | PubMed |
| Hemostatic defects in congenital disorders of glycosylation. | Res Pract Thromb Haemost | 2023 | 37193126 | PubTator, text mining | PubMed |
| An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis. | Int J Mol Sci | 2023 | 37175682 | PubTator, text mining | PubMed |
| Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. | Oncologist | 2023 | 37171998 | PubTator, text mining | PubMed |
| Genetic considerations in cerebral small vessel diseases. | Front Neurol | 2023 | 37168667 | PubTator, text mining | PubMed |
| What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future? | Res Pract Thromb Haemost | 2023 | 37168398 | PubTator, text mining | PubMed |
| Hemostatic protocol and risk-reduction surgery for treating coronary artery disease with aortic stenosis in a patient with combined coagulation factor VIII and XI deficiency: a case report. | Eur Heart J Case Rep | 2023 | 37168362 | PubTator, text mining | PubMed |
| "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions. | Front Cardiovasc Med | 2023 | 37153474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=22